An analysis of dysmenorrhoea and depressive symptoms in university students: A case-control study

2018 ◽  
Vol 24 (5) ◽  
pp. e12678 ◽  
Author(s):  
Tuba Uçar ◽  
Sermin Timur Taşhan ◽  
Yeşim Aksoy Derya ◽  
Gülçin Nacar
Keyword(s):  
Depressive Symptoms ◽  
University Students ◽  
Case Control Study ◽  
Case Control ◽  
Control Study

scholarly journals The association of depression with metabolic syndrome parameters and malondialdehyde (MDA) in obese women: A case-control study

2021 ◽  
Vol 11 (4) ◽  
pp. 492-497
Author(s):  
Elnaz Vaghef-Mehrabani ◽  
Azimeh Izadi ◽  
Mehrangiz Ebrahimi-Mameghani
Keyword(s):  
Oxidative Stress ◽  
Blood Pressure ◽  
Metabolic Syndrome ◽  
Depressive Symptoms ◽  
Lipid Profile ◽  
Case Control Study ◽  
Case Control ◽  
Obese Women ◽  
Anthropometric Parameters ◽  
Control Study

Background: There is evidence for a bidirectional association between obesity and depression, and obesity is the main risk factor for metabolic syndrome (MetS). This study aimed to compare oxidative stress and MetS features between depressed and non-depressed obese women and study the association of depressive symptoms, oxidative stress, and components of MetS. Methods: In this case-control study conducted in Tabriz (East Azarbaijan, Iran), obese women (body mass index [BMI]: 30-40 kg/m2 ) with a primary diagnosis of major depressive disorder (MDD; based on diagnostic interview with a psychiatrist; n=75) and their age-matched non-depressed controls (n=150) were enrolled. Beck Depression Inventory-version II (BDI-II) was used to assess depressive symptoms in both groups. Anthropometric parameters, blood pressure, fasting blood sugar (FBS), lipid profile and malondialdehyde (MDA) were measured. Results: No significant differences in anthropometric parameters and blood pressure were observed between the two groups. However, FBS of the MDD group was significantly higher than the control (P<0.05). FBS was significantly correlated with BDI-II scores (r=0.158, P=0.017). No significant difference in lipid profile was observed between the groups. Serum MDA level was significantly lower in the MDD group and was inversely associated with BDI-II scores (r=-0.328, P<0.001). Overall, MDD was not significantly associated with MetS in our study (OR=0.848, 95% CI: 0.484, 1.487; P=0.566). Conclusion: Although we found a correlation between higher depressive symptoms and some adverse metabolic outcomes, our findings do not support a significant association between MDD and MetS.

scholarly journals Factors associated to depressive symptoms in mothers with children hospitalized in pediatric and neonatology units of Peru: a case-control study

Medwave ◽  
2019 ◽  
Vol 19 (05) ◽  
pp. e7649-e7649 ◽  
Author(s):  
Kelly Macedo-Poma ◽  
Pavel Gustavo Marquina-Curasma ◽  
Ibraín Enrique Corrales-Reyes ◽  
Christian R. Mejía
Keyword(s):  
Depressive Symptoms ◽  
Case Control Study ◽  
Case Control ◽  
Factors Associated ◽  
Control Study

scholarly journals Mental health difficulties of adults with COVID-19-like symptoms in Bangladesh: a case control-study

2020 ◽  
Author(s):  
Musammet Rasheda Begum ◽  
Shafiqul Islam Khan ◽  
Hasan Al Banna ◽  
Satyajit Kundu ◽  
Munnaf Hossen ◽  
...  
Keyword(s):  
Mental Health ◽  
Logistic Regression ◽  
Depressive Symptoms ◽  
Online Survey ◽  
Case Control Study ◽  
Case Control ◽  
Anxiety Symptoms ◽  
Multivariate Logistic Regression ◽  
Mental Health Difficulties ◽  
Control Study

IntroductionThe rapid spread of SARS-CoV-2 coupled with inefficient testing capacities in Bangladesh has resulted in a number of deaths from COVID-19-like symptoms that have no official test results. Insufficient test sites and healthcare facilities catered to COVID-19 has led to feelings of fear and frustration in those who are sick. This study was the first study which explored the mental health of adults with the most common COVID-19-like symptoms in Bangladesh.MethodsThis retrospective case control study gathered data via an online survey to explore the mental health of Bangladeshi adults with symptoms akin to COVID-19. Level of stress, anxiety symptoms, and depressive symptoms were measured with the DASS-21. Chi-square tests and multivariate logistic regression was performed to examine the association of variables. ResultsThe prevalence rates of anxiety symptoms, and depressive symptoms of overall population were 26.9% and 52.0% respectively and 55.6% reported mild to extremely severe levels of stress. Multivariate logistic regression determined that respondents with COVID-19-like symptoms (case) reported higher odds for stress level (AOR: 2.043; CI: 1.51-2.76), anxiety symptoms (AOR: 2.770; CI: 2.04-3.77) and depressive symptoms (AOR: 1.482; CI: 1.12-1.96) than asymptomatic respondents (control). ConclusionPatients with symptoms like those of COVID-19 should be prioritized in the healthcare setting in order to reduce mental health difficulties throughout the pandemic.

scholarly journals Quality of Life and Anxious-depressive Symptoms in Cancer Patients Undergoing Mindfulness-based Interventions: Feasibility and Preliminary Outcomes on Prospective Single-centre Case-control Study (MIND4ME St.)

2017 ◽  
Vol 41 (S1) ◽  
pp. S252-S252
Author(s):  
G. Pontoni ◽  
M. Maur ◽  
R. Ferrari ◽  
A. Guida ◽  
S. Poletti ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Depressive Symptoms ◽  
Cancer Patients ◽  
Case Control Study ◽  
Psychological Symptoms ◽  
Daily Practice ◽  
Case Control ◽  
Depression And Anxiety ◽  
Control Study

BackgroundMindfulness based interventions (MBIs) have shown efficacy in improving psychological symptoms including depression and anxiety in cancer patients (pts). The study aimed to explore feasibility and reproducibility of MBIs in an Italian Cancer Centre measuring biochemical and psychological parameters.MethodsIn this pilot prospective case-control study, we recruited newly diagnosed pts receiving adjuvant chemotherapy (CT). A MBIs program was designed consisting of 2.5 hours weekly for 8 weeks and, including meditation, yoga and body scan. Material for 45 minutes (mn) home daily practice was provided. Primary endpoint was to evaluate feasibility. Secondary endpoints were assessment of quality of life (QoL), psychological and biochemical outcomes of stress, tested at baseline (W0), W4, W8, W24, W48. PSS (Perceived Stress Reduction), POMS (profile of mood states scores), EuroQoL (EQ-5D-3L) were administered.ResultsTen pts underwent MBIs program arm. We present preliminary results, while data of control arm are being collected. All pts were female, two pts (20%) dropped out. Median age was 56 years. All received adjuvant CT, 5/8 received radiotherapy and hormone therapy. Mean of sessions attending was 6.8 (76%). Median daily practice was 30 mn. EQ-5D item for depression and anxiety showed decreasing trend in mean score from moderate to light (P = 0.15) and significant improvement of auto-perceived QoL was observed comparing W0 and W8 (P = 0.02)ConclusionsIn a sensitive setting such as start CT, we found high pts compliance to MBIs. Improvement in self-perceived QoL after starting program was found and comparing anxious-depressive symptoms outcomes with control arm is still needed.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Quality of life, anxiety and depressive symptoms in patients with psoriasis: A case-control study

2019 ◽  
Vol 124 ◽  
pp. 109780 ◽  
Author(s):  
José M. Martínez-Ortega ◽  
Paloma Nogueras ◽  
José E. Muñoz-Negro ◽  
Luis Gutiérrez-Rojas ◽  
Pablo González-Domenech ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Depressive Symptoms ◽  
Case Control Study ◽  
Case Control ◽  
Control Study

scholarly journals Comorbidities, medications and depressive symptoms in patients with restless legs syndrome and migraine

2013 ◽  
Vol 71 (2) ◽  
pp. 87-91 ◽  
Author(s):  
Karen S. Ferreira ◽  
Alan Eckeli ◽  
Fabíola Dach ◽  
José G. Speciali
Keyword(s):  
Depressive Symptoms ◽  
Restless Legs Syndrome ◽  
Dopaminergic System ◽  
Case Control Study ◽  
Case Control ◽  
Control Group ◽  
Restless Legs ◽  
Symptoms Of Depression ◽  
Specific Factors ◽  
Control Study

OBJECTIVE: The pathophysiology of migraine and restless legs syndrome (RLS) seems to involve inherited mechanism and dysfunction of the dopaminergic system. Previous articles have shown that the frequency of RLS is higher in migraine patients than in controls. We conducted a study to evaluate comorbidities, medication used and depressive symptoms that can explain the relation between migraine and RLS. METHODS: A case-control study was performed in which patients with migraine (n=72) and a control group without migraine (n=72) were interviewed. Data including RLS diagnosis, depressive symptoms, comorbidities and drugs used were evaluated. RESULTS: There was a significant association between migraine and RLS (p=0.01), but comorbidities such as diabetes, hypertension, anemia and drugs used did not explain this association. Depression scores, as measured by the Beck Depression Inventory, were higher in migraine patients with RLS (p =0.04). CONCLUSION: No specific factors explaining the association between migraine and RLS were found. Symptoms of depression were more frequent in patients with migraine and RLS.

Sign in / Sign up

Export Citation Format

Share Document